Biological compounds for medical use in the nature of enhanced ribonucleic acid delivered into patient cells; biological compounds being a component in vaccines; therapeutic agents for generating protective immune response; biological therapeutic agents, namely molecularly engineered RNA for increasing expression and extending duration of expression of therapeutic proteins upon delivery into patient cells; all of the aforesaid excluding "G-protein-coupled receptors".;